Erratum: Bidirectional regulation between TMEFF2 and STAT3 may contribute to Helicobacter pylori-associated gastric carcinogenes (International Journal of Cancer (2015) 136:5 (1053-1064) DOI: 10.1002/ijc.29061);Bidirectional regulation between TMEFF2 and STAT3 may contribute to Helicobacter pylori-associated gastric carcinogenesis

International Journal of Cancer

Volumn 136, Issue 5, 2015, Pages 1053-1064

  Sun, Tian Tian ^a   Tang, Jia Yin ^b   Du, Wan ^a   Zhao, Hui Jun ^a   Zhao, Gang ^b   Yang, Sheng Li ^b   Chen, Hao Yan ^a   Hong, Jie ^a   Fang, Jing Yuan ^a,b  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Gastric cancer; H. pylori; STAT3; TMEFF2

Indexed keywords

EPIDERMAL GROWTH FACTOR; FOLLISTATIN; MEMBRANE PROTEIN; PROTEIN TYROSINE PHOSPHATASE SHP 1; STAT3 PROTEIN; TRANSMEMBRANE PROTEIN WITH EPIDERMAL GROWTH FACTOR AND TWO FOLLISTATIN MOTIF 2; UNCLASSIFIED DRUG; MESSENGER RNA; PTPN6 PROTEIN, HUMAN; STAT3 PROTEIN, HUMAN; TMEFF2 PROTEIN, HUMAN; TUMOR PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; GASTRIC CANCER CELL LINE; GENE; GENE CONTROL; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; MALE; MERIONES UNGUICULATUS; NONHUMAN; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; STOMACH CANCER; STOMACH CARCINOGENESIS; TMEFF2 GENE; ANIMAL; CELL TRANSFORMATION; CHROMATIN IMMUNOPRECIPITATION; ENZYME IMMUNOASSAY; GENE EXPRESSION REGULATION; GENETICS; GERBIL; METABOLISM; MICROBIOLOGY; PATHOGENICITY; PATHOLOGY; PHOSPHORYLATION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; STOMACH MUCOSA; STOMACH TUMOR; TUMOR CELL CULTURE;

ANIMALS; CELL TRANSFORMATION, NEOPLASTIC; CHROMATIN IMMUNOPRECIPITATION; GASTRIC MUCOSA; GENE EXPRESSION REGULATION, NEOPLASTIC; GERBILLINAE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MEMBRANE PROTEINS; NEOPLASM PROTEINS; PHOSPHORYLATION; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 6; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; STOMACH NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 84918827192     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.29830     Document Type: Erratum

References (44)

1. Jemal A, Bray F, Center MM, et al. Global cancer statistics. CA Cancer J Clin 2011;61:69-90.
2. Ueda T, Volinia S, Okumura H, et al. Relation between microRNA expression and progression and prognosis of gastric cancer: a microRNA expression analysis. Lancet Oncol 2010;11:136-46.
3. Cunningham D, Allum WH, Stenning SP, et al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med 2006;355:11-20.
4. Blaser MJ, Parsonnet J. Parasitism by the "slow" bacterium Helicobacter pylori leads to altered gastric homeostasis and neoplasia. J Clin Invest 1994;94:4-8.
5. Correa P. Is gastric carcinoma an infectious disease? N Engl J Med 1991;325:1170-1.
6. Bronte-Tinkew DM, Terebiznik M, Franco A, et al. Helicobacter pylori cytotoxin-associated gene A activates the signal transducer and activator of transcription 3 pathway in vitro and in vivo. Cancer Res 2009;69:632-9.
7. Mejýas-Luque R, Lindén SK, Garrido M, et al. Inflammation modulates the expression of the intestinal mucins MUC2 and MUC4 in gastric tumors. Oncogene 2010;29:1753-62.
8. Luo JJ, Li CY, Liu S, et al. Overexpression of Helicobacter pylori VacA N-terminal fragment induces proinflammatory cytokine expression and apoptosis in human monocytic cell line through activation of NF-jB. Can J Microbiol 2013;59:523-33.
9. Lamb A, Chen J, Blanke SR, et al. Helicobacter pylori activates NF-jB by inducing Ubc13-mediated ubiquitination of lysine 158 of TAK1. J Cell Biochem 2013;114:2284-92.
10. Tabassam FH, Graham DY, Yamaoka Y. Helicobacter pylori activate epidermal growth factor receptor- and phosphatidylinositol 3-OH kinasedependent Akt and glycogen synthase kinase 3beta phosphorylation. Cell Microbiol 2009;11:70-82.
11. Nagy TA, Frey MR, Yan F, et al. Helicobacter pylori regulates cellular migration and apoptosis by activation of phosphatidylinositol 3-kinase signaling. J Infect Dis 2009;199:641-51.
12. Franco AT, Israel DA, Washington MK, et al. Activation of beta-catenin by carcinogenic Helicobacter pylori. Proc Natl Acad Sci U S A 2005;102:10646-51.
13. Allison CC, Kufer TA, Kremmer E, et al. Helicobacter pylori induces MAPK phosphorylation and AP-1 activation via a NOD1-dependent mechanism. J Immunol 2009;183:8099-109.
14. Lee IO, Kim JH, Choi YJ, et al. Helicobacter pylori CagA phosphorylation status determines the gp130-activated SHP2/ERK and JAK/STAT signal transduction pathways in gastric epithelial cells. J Biol Chem 2010;285:16042-50.
15. Mimuro H, Suzuki T, Tanaka J, et al. Grb2 is a key mediator of helicobacter pylori CagA protein activities. Mol Cell 2002;10:745-55.
16. Kitajima Y, Ohtaka K, Mitsuno M, et al. Helicobacter pylori infection is an independent risk factor for Runx3 methylation in gastric cancer. Oncol Rep 2008;19:197-202.
17. Buti L1, Spooner E, Van Der Veen AG, et al. Helicobacter pylori cytotoxin-associated gene A (CagA) subverts the apoptosis-stimulating protein of p53 (ASPP2) tumor suppressor pathway of the host. Proc Natl Acad Sci U S A 2011;108:9238-43.
18. Yu XW, Xu Y, Gong YH, et al. Helicobacter pylori induces malignant transformation of gastric epithelial cells in vitro. APMIS 2011;119:187-97.
19. Horie M, Mitsumoto Y, Kyushiki H, et al. Identification and characterization of TMEFF2, a novel survival factor for hippocampal and mesencephalic neurons. Genomics 2000;67:146-52.
20. Lin K, Taylor JR Jr, Wu TD, et al. TMEFF2 is a PDGF-AA binding protein with methylationassociated gene silencing in multiple cancer types including glioma. PLoS One 2011;6:e18608.
21. Philipp AB, Stieber P, Nagel D, et al. Prognostic role of methylated free circulating DNA in colorectal cancer. Int J Cancer 2012;131:2308-19.
22. Costa VL, Henrique R, Danielsen SA, et al. Three epigenetic biomarkers, GDF15, TMEFF2, and VIM, accurately predict bladder cancer from DNA-based analyses of urine samples. Clin Cancer Res 2010;16:5842-51.
23. Sun TT, Du W, Xiong H, et al. TMEFF2 is downregulated in human gastric cancer and levels correlate with tumor progression and time of survival. Clin Cancer Res 2014, doi:10.1158/1078-0432.
24. Fu X, Beer DG, Behar J, et al. cAMP-response element-binding protein mediates acid-induced NADPH oxidase NOX5-S expression in Barrett esophageal adenocarcinoma cells. J Biol Chem 2006;281:20368-82.
25. Eads CA, Danenberg KD, Kawakami K, et al. MethyLight: a high-throughput assay to measure DNA methylation. Nucleic Acids Res 2000;28:E32.
26. Laine L, Lewin DN, Naritoku W, et al. Prospective comparison of H&E, Giemsa, and Genta stains for the diagnosis of Helicobacter pylori. Gastrointest Endosc 1997;45:463-7.
27. Bhang CS, Lee HS, Kim SS, et al. Effects of selective cyclooxygenase-2 inhibitor and non-selective NSAIDs on Helicobacter pylori-induced gastritis in Mongolian gerbils. Helicobacter 2002;7:14-21.
28. Out R, Hoekstra M, De Jager SC, et al. Adenovirusmediated hepatic overexpression of scavenger receptor class B type I accelerates chylomicron metabolism in C57BL/6J mice. J Lipid Res 2005;46:1172-81.
29. Judd LM, Bredin K, Kalantzis A, et al. STAT3 activation regulates growth, inflammation, and vascularization in a mouse model of gastric tumorigenesis. Gastroenterology 2006;131:1073-85.
30. Iype T, Sankarshanan M, Mauldin IS, et al. The protein tyrosine phosphatase SHP-1 modulates the suppressive activity of regulatory T cells. J Immunol 2010;185:6115-27.
31. Ahn KS, Sethi G, Sung B, et al. Guggulsterone, a farnesoid X receptor antagonist, inhibits constitutive and inducible STAT3 activation through induction of a protein tyrosine phosphatase SHP-1. Cancer Res 2008;68:4406-15.
32. Mauldin IS, Tung KS, Lorenz UM. The tyrosine phosphatase SHP-1 dampens murine Th17 development. Blood 2012;119:4419-29.
33. Uchida T, Wada K, Akamatsu T, et al. A novel epidermal growth factor-like molecule containing two follistatin modules stimulates tyrosine phosphorylation of erbB-4 in MKN28 gastric cancer cells. Biochem Biophys Res Commun 1999;266:593-602.
34. Glynne-Jones E, Harper ME, Seery LT, et al. TENB2, a proteoglycan identified in prostate cancer that is associated with disease progression and androgen independence. Int J Cancer 2001;94:178-84.
35. Zhao XY, Schneider D, Biroc SL, et al. Targeting tomoregulin for radioimmunotherapy of prostate cancer. Cancer Res 2005;65:2846-53.
36. Afar DE, Bhaskar V, Ibsen E, et al. Preclinical validation of anti-TMEFF2-auristatin E-conjugated antibodies in the treatment of prostate cancer. Mol Cancer Ther 2004;3:921-32.
37. Ali N, Knauper V. Phorbol ester-induced shedding of the prostate cancer marker transmembrane protein with epidermal growth factor and two follistatin motifs 2 is mediated by the disintegrin and metalloproteinase-17. J Biol Chem 2007;282:37378-88.
38. Gery S, Sawyers CL, Agus DB, et al. TMEFF2 is an androgen-regulated gene exhibiting antiproliferative effects in prostate cancer cells. Oncogene 2002;21:4739-46.
39. Kanda N, Seno H, Konda Y, et al. STAT3 is constitutively activated and supports cell survival in association with survivin expression in gastric cancer cells. Oncogene 2004;23:4921-9.
40. Judd LM, Alderman BM, Howlett M, et al. Gastric cancer development in mice lacking the SHP2 binding site on the IL-6 family co-receptor gp130. Gastroenterology 2004;126:196-207.
41. Kim DY, Cha ST, Ahn DH, et al. STAT3 expression in gastric cancer indicates a poor prognosis. J Gastroenterol Hepatol 2009;24:646-51.
42. Elahi A, Zhang L, Yeatman TJ, et al. HPP1-mediated tumor suppression requires activation of STAT1 pathways. Int J Cancer 2008;122:1567-72.
43. Yang J, Cai X, Lu W, et al. Evodiamine inhibits STAT3 signaling by inducing phosphatase shatterproof 1 in hepatocellular carcinoma cells. Cancer Lett 2013;328:243-51.
44. Chen KF, Chen HL, Liu CY, et al. Dovitinib sensitizes hepatocellular carcinoma cells to TRAIL and tigatuzumab, a novel anti-DR5 antibody, through SHP-1-dependent inhibition of STAT3. Biochem Pharmacol 2012;83:769-77.